Answers are grounded in this paper and cite their sources.
Background: Klebsiella pneumoniae is an important opportunistic pathogen increasingly associated with multidrug resistance and persistent healthcare-associated infections. Biofilm formation may enhance bacterial survival, reduce antimicrobial susceptibility, and contribute to treatment failure. This study evaluated the association between antimicrobial resistance phenotypes and biofilm-forming capacity among clinical isolates of K. pneumoniae. Materials and Methods: A prospective cross-sectional study was conducted over four months at Alluri Sitarama Raju Academy of Medical Sciences, Eluru, South India. A total of 150 non-duplicate clinical isolates of K. pneumoniae were included. Antimicrobial susceptibility testing was performed using the Kirby–Bauer disc diffusion method. Multidrug resistance, extended-spectrum β-lactamase production, and carbapenem resistance were assessed using standard phenotypic criteria. Results: Biofilm formation was detected in 115/150 (76.7%) isolates, comprising 20.7% weak, 30.0% moderate, and 26.0% strong biofilm producers. Multidrug resistance was observed in 94 (62.7%) isolates. MDR prevalence increased progressively from 40.0% among non-biofilm producers to 84.6% among strong biofilm producers (P<0.001). Biofilmpositive isolates had significantly higher odds of MDR than biofilm-negative isolates (OR 3.43; 95% CI: 1.56–7.51; P=0.002). Conclusion: A significant association was observed between biofilm-forming capacity and antimicrobial resistance among clinical K. pneumoniae isolates.
No takes yet. Share an insight, caveat, or question.
Das et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: